These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26540896)

  • 1. [GENERIC DRUGS: IS BIOEQUIVALENCE SUFFICIENT TO ENSURE QUALITY, EFFICACY AND SAFETY?].
    Carrillo Norte JA; Postigo Mota S
    Rev Enferm; 2015 May; 38(5):42-5. PubMed ID: 26540896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Generic drugs: we must cut pharmaceutical spending but undertaking drug quality].
    Carrillo Norte JA; Postigo Mota S
    Rev Enferm; 2012 Feb; 35(2):10-9. PubMed ID: 22670381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
    Chua GN; Hassali MA; Shafie AA; Awaisu A
    Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the European Medicines Agency's Development of Product-Specific Bioequivalence Guidelines.
    Sullivan JO; Blake K; Berntgen M; Salmonson T; Welink J;
    Clin Pharmacol Ther; 2018 Sep; 104(3):539-545. PubMed ID: 29319156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low quality of some generic cardiovascular medicinal products represents a matter for growing concern.
    Tamargo J; Rosano G
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):176-187. PubMed ID: 31501855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From antiretroviral originator to generic drugs: bioequivalence and pharmacovigilance.
    Bagheri H; Garraffo R; Dellamonica P
    Med Mal Infect; 2014 Oct; 44(10):464-9. PubMed ID: 25234382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current regulatory approaches of bioequivalence testing.
    Karalis V; Macheras P
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):929-42. PubMed ID: 22681436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on the need of multiple dose bioequivalence studies for prolonged-release generic products.
    García-Arieta A; Morales-Alcelay S; Herranz M; de la Torre-Alvarado JM; Blázquez-Pérez A; Suárez-Gea ML; Alvarez C
    Int J Pharm; 2012 Feb; 423(2):321-5. PubMed ID: 22120644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical considerations into the new EMA guideline on bioequivalence.
    Marzo A; Fontana E
    Arzneimittelforschung; 2011; 61(4):207-20. PubMed ID: 21650079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The implementation of the bioequivalence certification policy in Chile: An analysis of market authorization data.
    Kaplan WA; Cárdenas J; Mansilla C; Tobar T; Wirtz VJ
    PLoS One; 2019; 14(5):e0217334. PubMed ID: 31141565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of the switchability of generic products.
    Karalis V; Bialer M; Macheras P
    Eur J Pharm Sci; 2013 Nov; 50(3-4):476-83. PubMed ID: 23981332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generics: what is the role of registration authorities.
    Versantvoort C; Maliepaard M; Lekkerkerker F
    Neth J Med; 2008 Feb; 66(2):62-6. PubMed ID: 18292608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Views and perceptions about locally manufactured medicines in Ethiopia: a qualitative study of physicians, patients and regulatory authorities.
    Alemayehu C; Mitchell G; Nikles J; Aseffa A; Clavarino A
    BMC Health Serv Res; 2018 Aug; 18(1):624. PubMed ID: 30089496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Debate: Substitution of generic drugs in epilepsy: is there cause for concern?
    Gidal BE; Tomson T
    Epilepsia; 2008 Dec; 49 Suppl 9():56-62. PubMed ID: 19087118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
    Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G
    Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic and branded drugs for the treatment of people living with HIV/AIDS.
    Bartlett JA; Muro EP
    J Int Assoc Physicians AIDS Care (Chic); 2007 Mar; 6(1):15-23. PubMed ID: 17329500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modernization and Strengthening of Bioequivalence Guidelines in Japan.
    Kuribayashi R; Yamaguchi T; Takagi K
    Clin Pharmacokinet; 2021 Feb; 60(2):145-151. PubMed ID: 33247363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bioequivalence studies of pharmaceutical preparations].
    Vetchý D; Frýbortová K; Rabisková M; Danecková H
    Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition and Classification of Generic Drugs Across the World.
    Alfonso-Cristancho R; Andia T; Barbosa T; Watanabe JH
    Appl Health Econ Health Policy; 2015 Aug; 13 Suppl 1(Suppl 1):S5-11. PubMed ID: 26091708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.